Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
fontolizumab interferon gamma biotech NA drugbank , DGIDB Crohn Disease[MeSHID:D003424]
Disease[MeSHID:D004194]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Rheumatoid Arthritis[MeSHID:D001172]		 7.49 investigational unknown
fontolizumab interferon gamma biotech NA drugbank , DGIDB Crohn Disease[MeSHID:D003424]
Disease[MeSHID:D004194]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Rheumatoid Arthritis[MeSHID:D001172]		 7.49 investigational inhibitor
fontolizumab interferon-gamma NA Successful target TTD , DGIDB Crohn Disease[MeSHID:D003424]
Disease[MeSHID:D004194]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Rheumatoid Arthritis[MeSHID:D001172]		 7.49 discontinued in phase 2 inhibitor
fontolizumab interferon-gamma NA Successful target TTD , DGIDB Crohn Disease[MeSHID:D003424]
Disease[MeSHID:D004194]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Rheumatoid Arthritis[MeSHID:D001172]		 7.49 discontinued in phase 2 unknown
click here to return to the previous page